Clofarabine (Standard)
Clofarabine (Standard) is the analytical standard of Clofarabine. This product is intended for research and analytical applications. Clofarabine, a nucleoside analogue for research of cancer, is a potent inhibitor of ribonucleotide reductase (IC50=65 nM) by binding to the allosteric site on the regulatory subunit.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 98%
- CAS No.: 123318-82-1
- Formule: C10H11ClFN5O3
- Masse moléculaire:303.68
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Product Information
-
Chemical Information
- Pureté et documentation
-
Help & FAQs
-
HY-A0005
ClofarabineRibonucleotide Reductase Inhibitor -
HY-13605
CytarabineDNA Synthesis Inhibitor -
HY-B0069
FludarabineDNA Synthesis Inhibitor -
HY-13605R
Cytarabine (Standard)DNA Synthesis Inhibitor -
HY-17422
AcyclovirHSV Inhibitor -
HY-17026
GemcitabineDNA Synthesis Inhibitor -
HY-13599
CladribineDNA Synthesis Inhibitor -
HY-B0097
FloxuridineOncology Antimetabolite -
HY-13701
NelarabineNucleoside Analogue -
HY-13677
6-Mercaptopurine -
HY-13605A
Cytarabine hydrochlorideDNA Synthesis Inhibitor -
HY-B0003
Gemcitabine hydrochlorideDNA Synthesis Inhibitor
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 123318-82-1
-
Masse moléculaire 303.68
-
Formule C10H11ClFN5O3
-
SMILES
O[C@H]1[C@H](F)[C@H](N(C=N2)C3=C2C(N)=NC(Cl)=N3)O[C@@H]1CO
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Peter L Bonate, et al. Discovery and development of clofarabine: a nucleoside analogue for treating cancer. Nat Rev Drug Discov. 2006 Oct;5(10):855-63. [Content Brief]
[2]. Hai-Bo Liu, et al. [Effect of clofarabine on proliferation and Bcl-2 expression of NB4 cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Jun;20(3):571-3. [Content Brief]
[3]. Jia-Jie Luan, et al. Dosing-time contributes to chronotoxicity of clofarabine in mice via means other than pharmacokinetics. Kaohsiung J Med Sci. 2016 May;32(5):227-34. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Clofarabine (Standard) Related Classifications
HY-A0005R Related Classifications
Powered by Bioz